Literature DB >> 9765216

Biochemical and evolutionary significance of phospholipid methylation.

C J Walkey1, L Yu, L B Agellon, D E Vance.   

Abstract

All nucleated mammalian cells synthesize phosphatidylcholine from choline via the CDP-choline pathway. Hepatocytes have a second pathway for the synthesis of phosphatidylcholine, a stepwise methylation of phosphatidylethanolamine, catalyzed by phosphatidylethanolamine N-methyltransferase and encoded by the Pempt gene. We report that when Pempt-deficient mice were fed a choline-deficient diet for 3 days, severe liver pathology occurred apparently due to a lack of phosphatidylcholine biosynthesis. The hepatic concentration of phosphatidylcholine decreased by 50% compared with wild type mice on the diet. The levels of plasma triacylglycerols and cholesterol were decreased by greater than 90% in the Pempt-deficient mice. We suggest that the Pempt gene has been maintained during evolution to provide phosphatidylcholine when dietary choline is insufficient, as might occur during starvation or pregnancy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765216     DOI: 10.1074/jbc.273.42.27043

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

2.  Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline.

Authors:  Xiaonan Zhu; Jiannan Song; Mei-Heng Mar; Lloyd J Edwards; Steven H Zeisel
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 3.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

Review 4.  Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments.

Authors:  E Scorletti; P C Calder; C D Byrne
Journal:  Endocrine       Date:  2011-09-06       Impact factor: 3.633

5.  Maternal methionine adenosyltransferase I/III deficiency: reproductive outcomes in a woman with four pregnancies.

Authors:  S H Mudd; A Tangerman; S P Stabler; R H Allen; C Wagner; S H Zeisel; H L Levy
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

6.  Physiological consequences of disruption of mammalian phospholipid biosynthetic genes.

Authors:  Dennis E Vance; Jean E Vance
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

7.  The major sites of cellular phospholipid synthesis and molecular determinants of Fatty Acid and lipid head group specificity.

Authors:  Annette L Henneberry; Marcia M Wright; Christopher R McMaster
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

8.  From masochistic enzymology to mechanistic physiology and disease.

Authors:  Dennis E Vance
Journal:  J Biol Chem       Date:  2017-08-30       Impact factor: 5.157

Review 9.  Genetic polymorphisms in methyl-group metabolism and epigenetics: lessons from humans and mouse models.

Authors:  Steven H Zeisel
Journal:  Brain Res       Date:  2008-09-03       Impact factor: 3.252

Review 10.  Structure and function of phosphatidylcholine transfer protein (PC-TP)/StarD2.

Authors:  Keishi Kanno; Michele K Wu; Erez F Scapa; Steven L Roderick; David E Cohen
Journal:  Biochim Biophys Acta       Date:  2007-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.